ATE518846T1 - 2-aminooxazolderivate als für die behandlung von schmerzen geeignete trpvl-antagonisten - Google Patents
2-aminooxazolderivate als für die behandlung von schmerzen geeignete trpvl-antagonistenInfo
- Publication number
- ATE518846T1 ATE518846T1 AT08841479T AT08841479T ATE518846T1 AT E518846 T1 ATE518846 T1 AT E518846T1 AT 08841479 T AT08841479 T AT 08841479T AT 08841479 T AT08841479 T AT 08841479T AT E518846 T1 ATE518846 T1 AT E518846T1
- Authority
- AT
- Austria
- Prior art keywords
- pain
- treatment
- antagonists suitable
- trpvl antagonists
- aminooxazole
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical class NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000003566 TRPV1 Human genes 0.000 abstract 1
- 101150016206 Trpv1 gene Proteins 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98249007P | 2007-10-25 | 2007-10-25 | |
| US12/256,931 US7998993B2 (en) | 2007-10-25 | 2008-10-23 | TRPV1 antagonists |
| PCT/US2008/081229 WO2009055749A1 (en) | 2007-10-25 | 2008-10-25 | 2-aminooxazole derivatives as trpvl antagonists useful for treating pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE518846T1 true ATE518846T1 (de) | 2011-08-15 |
Family
ID=40227493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08841479T ATE518846T1 (de) | 2007-10-25 | 2008-10-25 | 2-aminooxazolderivate als für die behandlung von schmerzen geeignete trpvl-antagonisten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7998993B2 (de) |
| EP (2) | EP2220059B1 (de) |
| JP (1) | JP2011500852A (de) |
| CN (1) | CN101835762A (de) |
| AT (1) | ATE518846T1 (de) |
| CA (1) | CA2702976A1 (de) |
| MX (1) | MX2010004495A (de) |
| TW (1) | TW200934487A (de) |
| WO (1) | WO2009055749A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| US8722964B2 (en) * | 2009-04-23 | 2014-05-13 | Transposagen Biopharmaceuticals, Inc. | Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes |
| EP2449112A1 (de) | 2009-07-01 | 2012-05-09 | Transposagen Biopharmaceuticals, Inc. | Genetisch modifizierte rattenmodelle für schwere kombinierte immundefizienz (scid) |
| US20110145936A1 (en) * | 2009-07-30 | 2011-06-16 | Ostertag Eric M | Genetically Modified Rat Models for Pharmacokinetics |
| WO2011017518A2 (en) * | 2009-08-05 | 2011-02-10 | Transposagen Biopharmaceuticals, Inc. | Genetically modified rat models for drug metabolism |
| US8602579B2 (en) | 2009-09-25 | 2013-12-10 | Cree, Inc. | Lighting devices including thermally conductive housings and related structures |
| DK2790687T3 (en) | 2011-12-16 | 2018-11-19 | Poseida Therapeutics Inc | TRPC4 MODULATORS FOR USE IN TREATMENT OR PREVENTION OF Pain |
| JP6830569B1 (ja) | 2019-08-23 | 2021-02-17 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5151440A (en) * | 1990-02-28 | 1992-09-29 | Allergan, Inc. | Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines |
| KR20080014024A (ko) * | 2005-05-11 | 2008-02-13 | 아보트 러보러터리즈 | 바닐로이드 수용체 아형 1(vr1)의 길항제 및 이의 용도 |
-
2008
- 2008-10-23 US US12/256,931 patent/US7998993B2/en not_active Expired - Fee Related
- 2008-10-24 TW TW097141042A patent/TW200934487A/zh unknown
- 2008-10-25 AT AT08841479T patent/ATE518846T1/de not_active IP Right Cessation
- 2008-10-25 CA CA2702976A patent/CA2702976A1/en not_active Abandoned
- 2008-10-25 JP JP2010531302A patent/JP2011500852A/ja active Pending
- 2008-10-25 EP EP08841479A patent/EP2220059B1/de active Active
- 2008-10-25 WO PCT/US2008/081229 patent/WO2009055749A1/en not_active Ceased
- 2008-10-25 MX MX2010004495A patent/MX2010004495A/es unknown
- 2008-10-25 EP EP11176290A patent/EP2412372A1/de not_active Withdrawn
- 2008-10-25 CN CN200880113257A patent/CN101835762A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011500852A (ja) | 2011-01-06 |
| CN101835762A (zh) | 2010-09-15 |
| EP2220059A1 (de) | 2010-08-25 |
| EP2412372A1 (de) | 2012-02-01 |
| CA2702976A1 (en) | 2009-04-30 |
| US20090124666A1 (en) | 2009-05-14 |
| EP2220059B1 (de) | 2011-08-03 |
| US7998993B2 (en) | 2011-08-16 |
| MX2010004495A (es) | 2010-05-05 |
| TW200934487A (en) | 2009-08-16 |
| WO2009055749A1 (en) | 2009-04-30 |
| HK1147493A1 (en) | 2011-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| ATE439140T1 (de) | Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen | |
| EA201100748A1 (ru) | Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10 | |
| CY1117045T1 (el) | Ενωσεις κινουκλιδινης ως προσδετες του νικοτινικου υποδοχεα ακετυλχολινης αλφα-7 | |
| DE602006018057D1 (de) | Substituierte chinolone und verwendungsverfahren | |
| EA201070238A1 (ru) | Соединения пиримидина | |
| EA200870391A1 (ru) | Тетрагидропирролопиримидиндионы и их применение в качестве ингибиторов эластазы нейтрофилов человека | |
| CY1110901T1 (el) | Στερεοϊσομερεις ενωσεις και μεθοδοι για την αγωγη γαστρεντερικων διαταραχων και διαταραχων του κεντρικου νευρικου συστηματος | |
| DE602006010243D1 (de) | 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen | |
| EA201291236A1 (ru) | Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10 | |
| GEP20084550B (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
| UA101478C2 (ru) | Соединения, полезные как ингибиторы raf-киназы | |
| ATE553093T1 (de) | Indazolderivate zur hemmung von trpv1 und verwendungen davon | |
| EA201000550A1 (ru) | Производные тиазола | |
| MX2010001486A (es) | Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl. | |
| MX2010004495A (es) | Derivados de 2-aminooxazol como antagonistas de vanilloide-1 de receptor potencial transitorio (trpv1) utiles para tratar dolor. | |
| ATE441632T1 (de) | Gesättigte und ungesättigte 3-pyridyl- benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
| MX2010004498A (es) | Derivados de ciclohexenoamida y su uso como antagonistas de trpv1. | |
| CR8696A (es) | Beta-carbolinas utiles para tratar enfermedades inflamatorias | |
| EA200600860A1 (ru) | Производные n-тиазол-2-илбензамида | |
| DE602006017574D1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| EA200901179A1 (ru) | Замещённые тетрагидрохинолины | |
| DE602006017367D1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
| EA200702583A1 (ru) | Использование фенилсемикарбазонов для обработки семян |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |